Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity

D Newcomb1, G Bolgos, L Green

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.

Shock (Augusta, Ga.)
|August 29, 1998
PubMed

Insights

The broad-spectrum antibiotic imipenem (IMP) improved survival in mice after cecal ligation and puncture (CLP) compared to a triple antibiotic mixture (3AB). The 3AB treatment caused hypothermia and increased mortality, but not via elevated cytokines or lipopolysaccharide (LPS).

Area of Science:

  • Microbiology and Immunology
  • Pharmacology and Therapeutics
  • Sepsis and Critical Care Research

Background:

  • Antibiotic selection critically influences patient outcomes in sepsis.
  • The cecal ligation and puncture (CLP) model is a standard method for inducing polymicrobial sepsis in rodents.
  • Understanding antibiotic-specific physiological effects is crucial for optimizing sepsis treatment.

Purpose of the Study:

  • To compare the efficacy and physiological impact of imipenem (IMP) versus a triple antibiotic mixture (3AB) in a murine CLP model.
  • To investigate the mechanisms behind observed differences in survival and physiological responses, including temperature and activity.
  • To assess the role of cytokines and lipopolysaccharide (LPS) in mediating antibiotic-induced effects.

Main Methods:

  • Balb/c mice underwent CLP surgery.
  • Mice received either IMP, 3AB (gentamicin, clindamycin, ciprofloxacin), or dextrose (D5W) intravenously post-CLP.
  • Temperature and activity were monitored using Mini-Mitters; plasma and peritoneal cytokines (IL-1, IL-6, TNF, KC) and LPS were measured at specific time points.

Main Results:

  • Survival rates were significantly higher in the IMP group compared to the 3AB and D5W groups.
  • The 3AB treatment induced profound hypothermia and reduced nocturnal activity, effects not seen with IMP or D5W.
  • No significant differences in cytokine or LPS levels were found between the antibiotic treatment groups.

Conclusions:

  • Imipenem (IMP) demonstrates superior outcomes in a murine sepsis model compared to a triple antibiotic regimen (3AB).
  • The triple antibiotic mixture (3AB) is associated with increased morbidity and mortality, potentially due to hypothermia and reduced activity.
  • The detrimental effects of 3AB are not attributable to elevated systemic cytokine or LPS concentrations.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...